Untreated Adult Acute Myeloid Leukemia Completed Phase 2 Trials for Nilotinib (DB04868)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01806571 | Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | Treatment |